Although heterozygous ANGPTL3 loss-of-function variants were associated with a 41% lower odds of coronary artery disease, the median level of LDL-C in the heterozygous variants was approximately 112 mg/dL [50]. The gene discussed is ANGPTL3; the disease is coronary artery disorder.